Schwartz Norman D: insider trades.
Schwartz Norman D reported 6 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
- Transactions
- 6
- Purchases (P)
- 0
- Sales (S)
- 0
- Companies
- 1
- Name as filed
- SCHWARTZ NORMAN D
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Bio-Rad Laboratories, Inc. (BIO) | Director, Officer, TenPercentOwner · Chairman & CEO | 6 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-06 | Bio-Rad Laboratories, Inc. | M | 3,455 | $0 | 450,873 | Form 4 |
| 2026-09-06 | Bio-Rad Laboratories, Inc. | F | 1,854 | $386.11 | 449,019 | Form 4 |
| 2026-09-05 | Bio-Rad Laboratories, Inc. | F | 2,876 | $386.11 | 447,418 | Form 4 |
| 2026-09-05 | Bio-Rad Laboratories, Inc. | M | 4,109 | $0 | 450,294 | Form 4 |
| 2026-09-01 | Bio-Rad Laboratories, Inc. | M | 5,087 | $0 | 448,521 | Form 4 |
| 2026-09-01 | Bio-Rad Laboratories, Inc. | F | 2,336 | $380.96 | 446,185 | Form 4 |
Questions
What stock did Schwartz Norman D buy or sell?
Schwartz Norman D reported 6 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
Is Schwartz Norman D the same person as other filers with this name?
This page covers SEC CIK 940805 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/schwartz-norman-d-940805.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.